Member Info for Yorkshirepragma

Interesting debate to be had over ratio.
As you note .. several variables.
Play out of Covid could be several years globally . So forward earnjngs a factor.
My feelings are the PR machines ( governments, and media) will be a driving force in the valuation GF ( for Affimer testoutput)
Great share ...

Good read...
https://www.toptal.com/finance/valuation/biotech-valuation

ratio? EBITDA Guess 2021? £500m...? Ratio x6 .../M.Cap £3bn?
GLA

As a former Expat, concur with your experience.. UK needs some strategic bonuses...certainly the Affimer technology is perhaps a great example of this...just like the many other world leaders. The market need and more important the contribution to solving the worlds COVID problem will be stunning .
See Avacta revs, being £ several million /month and rising in near/ mid term and M.Cap, moving accordingly(up).

Patience needed here, but aware that all’s in hand ,and good hands too".

Comment: Revenues must attain £500m+ in mid-term,with potential only restricted by deployment volumes.
@ a conservative x 10-15 forward revenue typical biotech industry multiple ,then as you say ‘HIgher’.
...GLA

RK,
Thanks for insightful info. Appreciated.
As an old “PU “bod, understand line switching a restrictive game.
My guess is with a following wind , eastern capacity would move up to match demand as needs must . Number required - unknown as yet.
At least we know projects in good hands and has the impetus.
Diolch

Tim, Noted. ...my question is about assessing the availability of capacity that could be signed up ?...Tricky question .UK volume largely addressed. I have no idea what the WW cap. Might be and whether it’s accessible.
Ant experts out there?

That should read ...Also we need plastics production expertise....

RK. 100% Support that view..Alison we also need the plastic mod. Production expertise.Million dollar question is how swift do you think Avacta can swing into significant production?
Stage 1. BBI/ Abingdon... 1.5-2m units day? At most? And a stretch?
Thereafter the question is where’s the capacity...Far East ?
Thoughts?
Cheers

https://avance.ch/ubercooluploads/2018/12/Avance_on_PEratio.pdf
Just to keep feet On the ground... forward earnings x 10 -25 typical.
At the projected figs. Then certainly > current. 1-2bn ? M. Cap.y/e.
GLA

Jobs done...top Wetherby roumor..ows that...

Na point in’t sackless prattle.....Wetherby says ...dun...

If these volumes are achieved, their note will need revising!

Celerity not speed...it’ll not likely be in norm’ ts ...as you deferred to.

https://www.statista.com/statistics/1104645/covid19-testing-rate-select-countries-worldwide/

Well said..
Annual revenue...£2 x no Tests ...x 5 - 25 multiple = M.Cap end 2020.?
GLA

https://ourworldindata.org/coronavirus-testing

Avacta has only to manage its affairs reasonably going forward to achieve sig. revenue.
Restrictions ( as AS has outlined ) are production related,let’s hope the Finns & Italians can make enough machinery to achieve desired capacity . I suspect they will...
MCAP anyone?

Rich,
Very many thanks for positive comment. I think the board needs info for digestion?... I guess the main rationale here is that postAIM ( which can be a swift change by the company ) ,then based on likely earnings going forward ( even projected over say 3 years ) the market cap could readily accomplish the ‘billion’ level assuming that in next period projected revenue achieves Decent revenue from LFT Affimer sales .
I’m holding with expectations very similar to others, which are becoming more confirmed as matters progress.
GLA

https://avance.ch/ubercooluploads/2018/12/Avance_on_PEratio.pdf

Assuming earnings of X£ ...then multiple15-30

PL75...Nice one...

Ex-Sainsbury’s boss in ‘moonshot’ crony row

https://www.thetimes.co.uk/article/coronavirus-ex-sainsburys-boss-mike-coupe-to-take-over-as-test-and-trace-chief-f50ps8g5p?shareToken=5a2499724faa89537a9a0e883eddd651

PARA 5 ...couldn’t be clearer..

Ex-Sainsbury’s boss in ‘moonshot’ crony row

https://www.thetimes.co.uk/article/coronavirus-ex-sainsburys-boss-mike-coupe-to-take-over-as-test-and-trace-chief-f50ps8g5p?shareToken=5a2499724faa89537a9a0e883eddd651

Sent from my iPad